Clinical trials
Phase 1/2 Leukemia, Myeloid, Acute trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Completed | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 1 |
| Cell Medica Ltd | 1 |
| Constellation Pharmaceuticals | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Glycostem Therapeutics BV | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Incyte Corporation | 1 |
| Janssen Research & Development, LLC | 1 |
| Jules Bordet Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 14 |
| Leukemia | 6 |
| Myelodysplastic Syndromes | 6 |
| Recurrence | 4 |
| Hematologic Neoplasms | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Neoplasms | 2 |
| Primary Myelofibrosis | 2 |
| Blast Crisis | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.